Stages of Lyme Arthritis
Authors:
- 17 August 2020
- journal article
- review article
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 27 (8) , e540-e546
Abstract
Background/Historical Perspective: Lyme arthritis was described in 1977, after an apparent outbreak of juvenile idiopathic arthritis in Lyme, Connecticut. The evolution of the disease has been meticulously described with presentation dependent on disease duration and previous therapy. Summary Integrating Published Literature: Erythema migrans is typically the first manifestation. Untreated patients often develop early disseminated disease, characterized by migratory polyarthralgia, potentially with cardiac and/or neurologic sequelae. If untreated, most patients develop late Lyme arthritis, characterized as a monoarthritis or oligoarthritis, typically involving the knees. Serologies are strongly positive at this stage; if positive, Lyme PCR from synovial fluid confirms the diagnosis. Doxycycline is recommended for late Lyme arthritis, although amoxicillin or ceftriaxone may be considered. Initial antibiotic therapy for late Lyme arthritis is insufficient for a subset of patients. However, serologies and synovial fluid PCR are not useful at determining whether infection persists after oral therapy. As such, ceftriaxone is recommended in patients with inadequate response to doxycycline or amoxicillin. Approximately 10% of patients have persistent arthritis despite antimicrobial therapy, termed postinfectious Lyme arthritis, which is thought to be related to prolonged inflammation and unique microbial and host interaction. Therapy at this stage relies on immunosuppression and/or synovectomy. Major Conclusions and Future Research: Lyme arthritis provides unique insights into the complex interplay between microbes and host immunity. The progression from localized erythema migrans to early disseminated disease and late Lyme arthritis allows insight into arthritis initiation, and the study of postinfectious Lyme arthritis allows further insight into mechanisms of arthritis persistence.Keywords
This publication has 55 references indexed in Scilit:
- Association of a Toll‐like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic‐refractory Lyme arthritisArthritis & Rheumatism, 2012
- Borrelia burgdorferi RST1 (OspC Type A) Genotype Is Associated with Greater Inflammation and More Severe Lyme DiseaseThe American Journal of Pathology, 2011
- Burden and viability of Borrelia burgdorferi in skin and joints of patients with erythema migrans or lyme arthritisArthritis & Rheumatism, 2011
- Prospective Study of Serologic Tests for Lyme DiseaseClinical Infectious Diseases, 2008
- Searching for borrelial T cell epitopes associated with antibiotic-refractory Lyme arthritisMolecular Immunology, 2008
- Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind aBorrelia burgdorferipeptideJournal of Experimental Medicine, 2006
- Successful Parenteral Penicillin Therapy of Established Lyme ArthritisNew England Journal of Medicine, 1985
- Immune Complexes and the Evolution of Lyme ArthritisNew England Journal of Medicine, 1979
- Correlation of Serum and Cryoglobulin IgM with Activity, and Serum IgG with RemissionArthritis & Rheumatism, 1979
- Erythema Chronicum Migrans and Lyme Arthritis: Cryoimmunoglobulins and Clinical Activity of Skin and JointsScience, 1977